Fig 3. Left ventricular expression of TGF-β family receptors and ligands.
Compared to cKO-CON, cKO-TAM mice demonstrated (A) reduced mRNA levels of ALK-1 in the LV at 14 days after tamoxifen treatment. No change in (B–E) ALK-5, Endoglin, TGF-β1, BMP-7 or BMP-9 were observed in the cKO-TAM LV. *, p<0.05 vs. WT-TAM or cKO-CON; n=5/group.